Q3 2024 Holdings
Filed 2024-11-14 | 25 holdings | $279.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $29.9M | 200,285 | 10.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $25.1M | 511,041 | 9.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $23.4M | 204,987 | 8.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $19.6M | 520,119 | 7.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $18.5M | 1,712,899 | 6.6% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $18.5M | 1,002,461 | 6.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $17.5M | 331,283 | 6.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $15.8M | 874,590 | 5.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $15.1M | 298,974 | 5.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $14.1M | 946,335 | 5.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.0M | 22,111 | 4.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $9.7M | 501,978 | 3.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.7M | 481,127 | 3.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $7.5M | 648,019 | 2.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $7.2M | 1,368,810 | 2.6% |
| Merus N V | COM | N5749R100 | $6.6M | 131,240 | 2.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.4M | 556,489 | 2.3% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $5.7M | 432,996 | 2.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.6M | 109,567 | 2.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $4.6M | 1,120,409 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.6M | 37,432 | 0.9% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.0M | 195,704 | 0.7% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.5M | 77,297 | 0.5% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $1.1M | 47,266 | 0.4% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $1.1M | 31,529 | 0.4% |